Melbourne Digital Therapeutics develops evidence-based digital therapies for neurological and other health conditions.
Clinical-grade therapies that are accessible, scalable, and easy to deliver.
About
Built on science. Designed for real-world care.
Melbourne Digital Therapeutics transforms clinical expertise, scientific evidence, and novel technology into scalable digital therapies.
Beginning with SpeechATTAX, the MDTx platform continues to expand across domains of health.
Our Philosophy
-
To extend therapy beyond the clinic, improving continuity, scalability, and flexibility of care. Our products are designed to work seamlessly across settings, including home delivery, private practice, and large-scale operations.
-
To establish a multi-domain platform for premium care delivery. SpeechATTAX represents the foundation for a broader portfolio of healthcare solutions.
-
To let the evidence lead. We combine rigorous clinical research with extensive patient feedback, leading to dynamic and responsive therapies.
Introducing SpeechATTAX, the first digital therapeutic developed by MDTx.
SpeechATTAX is an evidence-based speech therapy for progressive neurological conditions.
The MDTx PlatformMDTX is ever-evolving. Our therapeutic targets span communication, cognition, movement, and beyond.
Science-led. Person-focused.
Science-led. Person-focused.
Get in Touch
We are interested in partnerships with clinicians, healthcare organisations, researchers, patient groups, and industry partners seeking to develop, evaluate or implement evidence-based digital therapies.
